1-1 of 1
Marco Chinol, PhD
Close
Sort by
Journal Articles

Efficacy of 90Y-Ibritumomab Tiuxetan in Marginal-Zone Lymphoma (MZL).

Anna Vanazzi, MD, Pier Francesco Ferrucci, MD, Chiara Grana, MD, Giancarlo Pruneri, MD, Cristiano Crosta, MD, Antonello Pinto, MD, Marco Chinol, PhD, Giovanni Paganelli, MD, Giovanni Martinelli, MD
Journal: Blood
Blood (2007) 110 (11): 4499.
https://doi.org/10.1182/blood.V110.11.4499.4499
Published: 2007